The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The benefit of cost-sharing subsidies in the treatment of chronic myeloid leukemia (CML) after price surging of tyrosine kinase inhibitors (TKIs).
 
Erlene Kuizon Seymour
No Relationships to Disclose
 
Julie George
No Relationships to Disclose
 
Julie J. Ruterbusch
No Relationships to Disclose
 
Jennifer Lynn Beebe-Dimmer
No Relationships to Disclose
 
Charles Alan Schiffer
Consulting or Advisory Role - Ambit BioSciences; Ambit BioSciences; Astellas Pharma; Celgene; Curis; Juno Therapeutics; Juno Therapeutics; PFIZER; Pharmacyclics; TAKEDA; TEVA
Research Funding - ARIAD (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Micromedic (Inst); Novartis (Inst)